Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy

Journal of Neuroscience Methods

Volumn 87, Issue 1, 1999, Pages 111-115

  Braak, Eva ^a   Braak, Heiko ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Argyrophilic oligodendrocytes; Cytokeletal alterations; Lewy bodies; Lewy body disease; Lewy neurites; Multiple system atrophy; Parkinson's disease; Silver staining

Indexed keywords

ARTICLE; AUTOPSY; BRAIN BIOPSY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FROZEN SECTION; HUMAN; HUMAN TISSUE; LEWY BODY; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; SILVER STAINING; TISSUE PREPARATION;

BRAIN; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MULTIPLE SYSTEM ATROPHY; OLIGODENDROGLIA; PARAFFIN EMBEDDING; PARKINSON DISEASE; SILVER STAINING; TISSUE FIXATION;

EID: 0033083758     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(98)00173-3     Document Type: Article

References (29)

1. Arai N., Nishimura M., Oda M., Morimatsu Y., Ohe R., Nagatomo H. Immunohistochemical expression of microtubule-associated protein 5 (MAPS) in glial cells in multiple system atrophy. J. Neurol. Sci. 109:1992;102-106.
2. Braak H., Braak E., Ohm T., Bohl J. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain. Technol. 63:1988;197-200.
3. Braak H., Braak E., Yilmazer D., de Vos R.A.I., Jansen E.N.H., Bohl J. Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J. Neural. Transm. [D Sect]. 103:1996;455-490.
4. Campbell S.K., Switzer R.C., Martin T.L. Alzheimer's plaques and tangles: a controlled and enhanced silver staining method. Soc. Neurosci. Abstr. 13:1987;678.
5. Ciss S., Perry G., Lacoste-Royal G., Cabana T., Gauvreau D. Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains. Acta Neuropathol. 85:1993;233-240.
6. Costa C., Duyckaerts C., Cervera P., Hauw J.J. Les inclusions oligodendrogliales, un marqueur des atrophies multisystématisées. Rev. Neurol. (Paris). 148:1992;274-280.
7. Dickson D.W., Wertkin A., Kress Y., Ksiezak-Reding H., Yen S.H. Ubiquitin immunoreactive structures in normal human brain. Distribution and developmental aspects. Lab. Invest. 63:1990;87-99.
8. Fearnley J., Lees A. Pathology of Parkinson's disease. Calne D.B. Neurodegenerative Diseases. 1994;545-554 Saunders, Philadelphia, PA.
9. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morph. Acad. Sci. Hung. 19:1971;1-8.
10. Gallyas F. Light insensitive physical developers. Stain. Technol. 54:1979;173-176.
11. Gallyas F., Hsu M., Buzsaki G. Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue-dark neurons, perikarya of all neurons, microglial cells and capillaries. J. Neurosci. Methods. 50:1993;159-164.
12. Gibb W.R.G., Lees A.J. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol. Appl. Neurobiol. 15:1989;27-44.
13. Gibb W.R.G., Scott T., Lees A.J. Neuronal inclusions of Parkinson's disease. Movement Disorders. 6:1991;2-11.
14. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J. Neurol. Neurosurg. Psych. 55:1992;181-184.
15. Iqbal K., Braak H., Braak E., Grundke-Iqbal I. Silver labeling of Alzheimer neurofibrillary changes and brain β-amyloid. J. Histotechnol. 16:1993;335-342.
16. Jellinger K. Pathology of Parkinson's disease. Calne D.B. Handbook of Experimental Pharmacology. Drugs for the Treatment of Parkinson's Disease. 88:1989;47-112 Springer, Berlin.
17. Kato S., Nakamura H., Hirano A., Ito H., Llena J.F., Yen S.H. Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy). Acta Neuropathol. 82:1991;488-493.
18. Kuzuhara S., Mori H., Izumiyama N., Yoshimura M., Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. 75:1988;345-353.
19. Leigh P.N., Probst A., Dale G.E., Power D.P., Brion J.P., Dodson A., Anderton B.H. New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol. 79:1989;61-72.
20. Lennox G., Lowe J., Landon M., Byrne E.J., Mayer R.J., Godwin-Austen R.B. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J. Neurol. Neurosurg. Psych. 52:1989;1236-1247.
21. Love S., Nicoll J.A.R. Comparison of modified Bielschowsky silver impregnation and anti-ubiquitin immunostaining of cortical and nigral Lewy bodies. Neuropathol. Appl. Neurobiol. 18:1992;585-592.
22. Lowe J. Lewy bodies. Calne D.P. Neurodegenerative Diseases. 1994;51-69 Saunders, Philadelphia, PA.
23. Murayama S., Arima K., Nakazato Y., Satoh J.I., Oda M., Inose T. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multpiple system atrophy. 2: Oligodendroglial cytoplasmic inclusions. Acta. Neuropathol. 84:1992;32-38.
24. Nakazato Y., Yamazaki H., Hirato J., Ishida Y., Yamaguchi H. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J. Neuropathol. Exp. Neurol. 49:1990;521-530.
25. Papp M.I., Kahn J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci. 94:1989;79-100.
26. Papp M.I., Lantos P.L. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J. Neurol. Sci. 107:1992;172-182.
27. Papp M.I., Lantos P.L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain. 11:1994;235-243.
28. Pollanen M.S., Dickson D.W., Bergeron C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52:1993;183-191.
29. Smithson K.G., MacVicar B.A., Hatton G.I. Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J. Neurosci. Methods. 7:1983;27-41.